Maves Review

Maves: a performance-framed GLP-1 plan with an aggressive first-month hook

Maves is the consumer-facing brand of Homera Health, and it sells weight loss differently than most telehealth clinics. Instead of the usual disease-and-BMI framing, it leans into a body-optimization pitch — fat loss, lean muscle, and energy — and pairs compounded semaglutide and tirzepatide with sermorelin, an anti-aging add-on you won't find at a typical GLP-1 startup. If that performance angle speaks to you and the headline number does the rest, Maves is easy to start. The catch is that the eye-catching $99 rate is a first-month intro, and a few of the things careful shoppers look for aren't published. It's worth it for the right person, but go in knowing exactly what's disclosed and what isn't.

How the pricing actually works

The number you see everywhere — $99 — is semaglutide's first-month price, not a permanent rate. Maves describes it as 'starting at' that figure, and it does not publish what the standard refill price steps up to after month one. That's the single most important thing to clarify before you sign up. For comparison, the category median we track sits at $169 a month, so the intro rate is genuinely among the most aggressive we've seen — the open question is where the ongoing price lands.

What the plan price does include is unusually clean. Maves bundles the medical consultation, your prescription medication when a provider approves it, ongoing clinical support, and free shipping, and it explicitly states there are no hidden or additional fees. That all-inclusive structure matters because plenty of competitors quote a low medication price and then layer a separate consult fee or membership charge on top. Sermorelin, the anti-aging peptide, is priced separately as its own add-on in the low three figures per month.

• Semaglutide: $99 first month, with the standard refill price not published
• Tirzepatide: offered, but no price is listed anywhere on the site
• Sermorelin: a separate anti-aging add-on in the low three figures monthly
• Bundled in every plan: consult, medication when approved, clinical support, free shipping — no extra fees

The medications and how they're dispensed

Maves dispenses compounded semaglutide and tirzepatide — the same active ingredients as the brand-name injectables, made to order by a compounding pharmacy rather than a major manufacturer. To its credit, Maves publishes the FDA's compounded-medication disclaimer right on the homepage: these formulations are not reviewed or approved by the FDA for safety or effectiveness, a prescription is required, and results vary. Seeing that stated plainly is a good-faith signal many compounding sellers bury or skip entirely.

The weak spot is sourcing transparency. Maves says your medication comes from 'licensed U.S. pharmacies,' but it never names the specific 503A compounding pharmacy or shares its address. You're trusting the brand's vetting rather than being able to look up the pharmacy yourself. If knowing exactly which pharmacy fills your prescription is important to you, that gap is worth weighing.

What sets Maves apart

Two things genuinely distinguish it. First is the performance positioning: Maves frames GLP-1 therapy around fat loss, lean muscle, and optimized energy, and folds in sermorelin as an anti-aging option. That's a deliberate men's-health and body-optimization spin on a market that usually talks in clinical weight-loss terms, and it'll resonate with people who think about their bodies that way. Second is the corporate honesty about who's behind it — the consumer brand 'Maves' and the parent company 'Homera Health' are both disclosed, with the parent's site and patient login portal referenced openly. Naming the parent entity is a small accountability marker that a lot of single-brand telehealth shops don't bother with.

Who it's for — and who should skip it

Maves fits someone drawn to the performance and body-composition framing who wants to start fast at a low entry price and values an all-inclusive plan with no surprise fees. Coverage in all 50 states, stated explicitly, means location won't be a barrier.

Skip it, or at least slow down, if you need the full picture before committing. The standard refill price isn't shown, so you can't model month two and beyond. Tirzepatide is listed as an option but carries no published price at all. And there's no named medical director, no public refund or cancellation policy, and no corporate address or arbitration venue on the site. None of those is disqualifying on its own, but together they mean you'll be filling in blanks by emailing support rather than reading them off the page.

Trust, safety, and medical oversight

This is where Maves earns more confidence than its disclosure gaps might suggest. It carries a verifiable LegitScript certification (ID 46200381), which you can check directly — that's the meaningful third-party accreditation for a telehealth pharmacy operation, and it's not something a fly-by-night site can fake. Combined with the published FDA compounded disclaimer, the explicit all-50-states statement, and the brand-plus-parent corporate disclosure, those signals are why we rate our verification confidence in Maves as high. There are no FDA warning letters on file against it. The honest counterweight: care is delivered by unnamed 'licensed medical providers' with no clinical leader identified, so the oversight is real but not personally attributable. You can read how we weigh these factors in our scoring methodology.

Bottom line

Maves is a credible, LegitScript-certified way to start compounded semaglutide at one of the lowest first-month prices we track, wrapped in a performance-and-anti-aging pitch that will appeal to a specific kind of patient. It's transparent where it counts most — accreditation, FDA status, and who owns the brand — but quiet on the details that govern the long haul: the standard refill price, tirzepatide's cost, the pharmacy's name, and the refund terms. Treat $99 as a door-opener, confirm the ongoing rate and cancellation policy in writing before you commit, and it's a reasonable pick. Go in expecting that lasting low price without checking, and you may be surprised at refill time.

If you're weighing alternatives, Sunlight ($88/month) and bmiMD ($99/month) are among the closest options we track to Maves.